Search Results for 'sof rbv'

sof rbv published presentations and documents on DocSlides.

by debby-jeon

SOF + RBV. Randomisation*. 1 : 1 : 1. Open-label....

Daclatasvir + Sofosbuvir + RBV in GT3

Daclatasvir + Sofosbuvir + RBV in GT3

by sophia2

. with Advanced Liver Disease. ALLY-3+ Study. Phas...

SOF + EBR + GZR + RBV

SOF + EBR + GZR + RBV

by test

N = 12. N = 13. W24. W16. SOF + EBR + GZR + RBV. ...

by trish-goza

400/100 mg . qd. N = 120. N = 120. W12. SOF + RBV...

by celsa-spraggs

N = 69. >. 18 years. Failure to SOF/VEL . or ...

by tawny-fly

Placebo. LDV/SOF + placebo. Randomisation*. 1 : 1...

Hepatitis C Drug Pipeline

Hepatitis C Drug Pipeline

by cheryl-pisano

HCV WORLD CAB .  FEBRUARY 2014. BANGKOK, THAI...

by sherrill-nordquist

SOF + SMV + RBV. SOF + SMV. Randomisation. 2 : 1 ...

Chronic hepatitis C: guidelines for screening and

Chronic hepatitis C: guidelines for screening and

by aaron

treatment. Lisa M. Glass, MD. Clinical Lecturer. ...

FISSION Design Objective

FISSION Design Objective

by travis

Non . inferiority. of SOF + RBV : SVR. 12. (. 2-...

HIV and HCV Update for the Pharmacist – June 2014

HIV and HCV Update for the Pharmacist – June 2014

by marina-yarberry

John J. . Faragon. , . PharmD. , BCPS, AAHIV-P. R...

Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology

Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology

by badra

Duke University School of Medicine. Durham, North ...

Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care

Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care

by webraph

Sameh W. Boktor, MD, MPH. Medical Epidemiologist. ...

HCV Clinical Management TRAINER(S)

HCV Clinical Management TRAINER(S)

by trish-goza

IAPAC African Regional Capacity-Building Hub. Bas...

Hepatitis C Imtiaz Alam, M.D.

Hepatitis C Imtiaz Alam, M.D.

by olivia-moreira

Medical Director, Austin Hepatitis Center. 1. Hep...

HCV Clinical Management TRAINER(S)

HCV Clinical Management TRAINER(S)

by danika-pritchard

IAPAC African Regional Capacity-Building Hub. Bas...

Prevention strategies for HIV/HCV co infection

Prevention strategies for HIV/HCV co infection

by giovanna-bartolotta

Isabelle Andrieux-Meyer, MD. Médecins Sans Front...

Updated Guidelines for Managing HIV/HCV Co-Infection

Updated Guidelines for Managing HIV/HCV Co-Infection

by karlyn-bohler

John J . Faragon. , . PharmD. , BCPS, AAHIV-P. Re...

Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care

Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care

by lois-ondreau

Sameh W. Boktor, MD, MPH. Medical Epidemiologist....

Out With the Old and In With the New, Again?

Out With the Old and In With the New, Again?

by test

Out With the Old, In With the New. Current Standa...

Sofosbuvir + Peginterferon + Ribavirin in Genotype 2

Sofosbuvir + Peginterferon + Ribavirin in Genotype 2

by debby-jeon

. or 3 . LONESTAR-2. Phase 2. Treatment. . Exp...

Ledipasvir-Sofosbuvir + RBV in Decompensated Cirrhosis or Post-Liver Transplantation

Ledipasvir-Sofosbuvir + RBV in Decompensated Cirrhosis or Post-Liver Transplantation

by ahmir653

SOLAR-2. Source: . Manns. M, et al. Lancet Infect...

SOF/VEL 400/100 mg qd N = 75

SOF/VEL 400/100 mg qd N = 75

by danika-pritchard

W24. SOF/VEL. >. 18 years. Chronic HCV infect...

by giovanna-bartolotta

Genotype . 2. . or 3 . FUSION. Trial. Phase . ...

Ledipasvir-Sofosbuvir RBV in HCV GT 1,4 and Advanced Liver Disease

Ledipasvir-Sofosbuvir RBV in HCV GT 1,4 and Advanced Liver Disease

by alida-meadow

SOLAR-1 (Cohorts A and B). Phase . 2 . Treatment ...

Daclatasvir in Combination With Sofosbuvir

Daclatasvir in Combination With Sofosbuvir

by mitsue-stanley

With Or Without Ribavirin Is Safe and Efficacious...

Daclatasvir in Combination With Sofosbuvir

Daclatasvir in Combination With Sofosbuvir

by mitsue-stanley

With Or Without Ribavirin Is Safe and Efficacious...

Sofosbuvir, Ribavirin, GS

Sofosbuvir, Ribavirin, GS

by min-jolicoeur

-. 0938 in GT 1-4. QUANTUM. Phase . 2b. Treatment...

Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:

Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:

by kittie-lecroy

Interim Analysis of a French Multicenter Compassi...

EASL 2019 HCV Conference Update

EASL 2019 HCV Conference Update

by sophia

April 10. –14. , 2019. Vienna, Austria. Disclaim...

Safety and Efficacy of Daclatasvir

Safety and Efficacy of Daclatasvir

by tabitha

. Plus . Sofosbuvir. With or Without Ribavirin . ...

Treatment of Chronic Hepatitis C Virus Infection in Adults

Treatment of Chronic Hepatitis C Virus Infection in Adults

by tracy

www.hivguidelines.org. APRIL 2023. NYSDOH AIDS Ins...

Use of HCV DAAs with HIV Regimens

Use of HCV DAAs with HIV Regimens

by robaut

Sam Lam, . PharmD. Annie Vong, . PharmD. 2/3/2017....

HIV Pipeline Cabotegravir-LA

HIV Pipeline Cabotegravir-LA

by liane-varnes

(GSK-744; CAB). For . PrEP. INI. ViiV. Topical mi...

Community Pharmacy Considerations for HIV

Community Pharmacy Considerations for HIV

by tawny-fly

& HCV . Therapy. Larry Pineda, . PharmD. , . ...

HIV Pipeline Doravirine 2

HIV Pipeline Doravirine 2

by giovanna-bartolotta

(MK-1439; DOR). . NNRTI. Merck. Filed with USFDA...

by stefany-barnette

Design. Objective. SVR. 12. (HCV RNA < 25 IU/...

2013 Asilomar HIV Medical Update

2013 Asilomar HIV Medical Update

by luanne-stotts

David Spach, MD. Clinical Director, Northwest AET...

Ledipasvir-Sofosbuvir (

Ledipasvir-Sofosbuvir (

by lindy-dunigan

Harvoni. ). Prepared by: . David H. Spach, MD and...

Are Pan-Genotypic Therapies Ready for Prime Time?

Are Pan-Genotypic Therapies Ready for Prime Time?

by lois-ondreau

3. Rd. International . HIV/Hepatitis . Coinfecti...